Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.98
+0.08 (0.67%)
Feb 4, 2026, 3:00 PM CST

SHA:603439 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
265.69476.07571.37570.88544.22450.05
Short-Term Investments
-----130
Trading Asset Securities
59.722.9551.559.9198-
Cash & Short-Term Investments
325.4499.02622.87630.79642.22580.05
Cash Growth
-45.14%-19.89%-1.26%-1.78%10.72%142.08%
Accounts Receivable
700.57932.12682.86432.82312.8288.77
Other Receivables
4.672.533.322.1851.410.86
Receivables
705.25934.65686.18435.01364.21289.63
Inventory
324.73320.72175.7298.0888.5747.51
Other Current Assets
53.8543.598.698.184.552.83
Total Current Assets
1,4091,7981,4931,1721,100920.01
Property, Plant & Equipment
540.3585.15615.13237.4157.91154.36
Long-Term Investments
89.5722.5510.08129.77119.13167.82
Goodwill
554.61554.61554.61161.66--
Other Intangible Assets
198.95216.13235.23107.320.3811.84
Long-Term Deferred Tax Assets
14.5215.1311.086.895.124.76
Long-Term Deferred Charges
0.640.560.861.542.9-
Total Assets
2,8483,1922,9201,8171,4051,259
Accounts Payable
135.35342.73247.98165.2698.8435.38
Accrued Expenses
4.4267.3339.4831.3316.5912.58
Short-Term Debt
575.48351.52255.32205200200
Current Portion of Long-Term Debt
52.7145.1545.22---
Current Portion of Leases
-0.50.150.5--
Current Income Taxes Payable
20.2313.8412.7710.919.47.61
Current Unearned Revenue
7.747.798.1778.965.835.89
Other Current Liabilities
177.42405.59229.9256.7229.762.45
Total Current Liabilities
973.371,234839.01548.68360.42263.91
Long-Term Debt
179.4209.3254.15---
Long-Term Leases
0.050.210.170.17--
Long-Term Unearned Revenue
39.9142.9735.9712.512.513
Long-Term Deferred Tax Liabilities
22.8725.528.886.94--
Other Long-Term Liabilities
84.4385.0452.9210.1--
Total Liabilities
1,3001,5971,211578.4372.93276.91
Common Stock
409.8409.8409.86410.86410.86407.32
Additional Paid-In Capital
159.23149.04225.12229.69223.39201.27
Retained Earnings
1,0121,069876.75625.04423.75373.3
Treasury Stock
-100.64-100.64-41.43-26.55-26.55-
Total Common Equity
1,4811,5271,4701,2391,031981.89
Minority Interest
67.4767.29239.04-0.820.61-0.02
Shareholders' Equity
1,5481,5951,7091,2381,032981.88
Total Liabilities & Equity
2,8483,1922,9201,8171,4051,259
Total Debt
807.65606.68555.02205.67200200
Net Cash (Debt)
-482.25-107.6767.86425.12442.22380.05
Net Cash Growth
---84.04%-3.87%16.36%58.61%
Net Cash Per Share
-1.20-0.260.161.031.070.97
Filing Date Shares Outstanding
405.61405.61408.25410.86410.86407.32
Total Common Shares Outstanding
405.61405.61408.25410.86410.86407.32
Working Capital
435.86563.53654.46623.38739.12656.1
Book Value Per Share
3.653.773.603.022.512.41
Tangible Book Value
727.13756.61680.48970.091,011970.05
Tangible Book Value Per Share
1.791.871.672.362.462.38
Buildings
-543.28549.09181.14152.85152.85
Machinery
-351.45344.91103.2758.4448.76
Construction In Progress
--0.0448.594.170.27
Source: S&P Global Market Intelligence. Standard template. Financial Sources.